New research conducted at Rutgers Health, led by Dr. Naveena Yanamala, PhD, FASE, has demonstrated that the XForce Tourniquet, developed by Auric Innovations, significantly outperformed the industry-standard Combat Application Tourniquet (CAT) in application speed and usability. The study, published on a preprint server medRxiv, found that the XForce Tourniquet reduced total application time by 47% compared to CAT Tourniquet, marking a major advancement in emergency hemorrhage control.
The research was funded by the New Jersey Commission on Science, Innovation, and Technology (CSIT) as part of its initiative to support medical innovation and startup development in New Jersey. The Center for Innovation at Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital provided resources and facilities for data collection and analysis.
